A defendant shall be punished by imprisonment for six months and a fine of five million won.

However, the above imprisonment for two years from the date this judgment becomes final and conclusive.

Punishment of the crime

The defendant is a person who operates a stock company C with the purpose of selling and selling household goods, miscellaneous wholesale and retail in Suwon-si, Suwon-si B.

1. Non-pharmaceuticals in violation of the Pharmaceutical Affairs Act refer to fiber, rubber products or similar products used for the purpose of treating, alleviating, treating, or preventing human or animal diseases, which are designated by the Minister of Food and Drug Safety; yellow dust and fine dust and other products used for the purpose of protecting respiratorys from sources of toxic harmful substances or infection, fall under non-pharmaceuticals to which the Pharmaceutical Affairs Act applies in accordance with the Public Notice of Designation of Non-pharmaceuticals (Public Notice of the Ministry of Food and Drug Safety No. 2019-86); and KF94 health masts are health masts that can grow at least 94% of the average of 0.4 p.m.;

A person who intends to engage in the business of manufacturing quasi-drugs shall be equipped with necessary facilities in accordance with the facility standards prescribed by Presidential Decree and shall report the manufacturing business to the Minister of Food and Drug Safety and obtain marketing approval or report item for each item, and no person shall include false or misleading matters concerning the relevant quasi-drugs on the containers or packages of quasi-drugs, and shall sell such quasi-drugs, store or display them for sale.

From February 21, 2020 to February 20, 2020, the Defendant manufactured 2,400 Mak-type Mak-type Mak-type Makk-type Makk-type 2,400 won per unit after manufacturing 2,00 Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak-type Mak

Accordingly, the defendant manufactures non-pharmaceutical drugs without reporting manufacturing business and marketing approval to the Minister of Food and Drug Safety, and entered false or misleading matters concerning non-pharmaceutical drugs on the packages of non-pharmaceutical drugs, and such non-pharmaceutical drugs are included.